Moran Shemesh
Analyst · Deutsche Bank. Please proceed
Thank you, Amnon, and thanks for joining the call, everyone. Before I begin, please be aware that all my comments on profitability will refer to non-GAAP measurements. The primary exclusion in Mobileye’s non-GAAP numbers is amortization of intangible assets, which is mainly related to Intel's acquisition of Mobileye in 2017. We also exclude stock-based compensation. Starting with Q4 results, we had another very good quarter with revenue up 13% year-over-year, adjusted operating income up 14%, and adjusted operating margin at 39%. SuperVision volumes were 38,000 units in Q4, up from 29,000 in Q3. The 67,000 units we did in the second half was significantly higher than 35,000 in the first half. Operating expenses were again meaningfully below expectations, about $30 million this quarter. There were two main areas, each about the same magnitude. Favorable expenses were lower due to favorable ethics and due to some reimbursement for employees on military reserve duty. The other factor was higher than expected engineering reimbursement for pre-designed win activities with certain OEMs. Over the course of 2023, our operating margin rose from 27% to 39% on sequentially higher revenue and consistent operating expenses. Obviously, this is a backward-looking, but it should give investors some sense of the operating leverage possible once more meaningful SuperVision and Chauffeur volumes start to drive revenue significantly higher. On a cashflow basis, we generated almost $400 million of operating cashflow in fiscal year 2023. And it's important to note that we invested around $200 million in rebuilding the safety buffer of EyeQ chips on our own balance sheet. We expect to maintain a consistent level of balance sheet inventory in 2024. Capital expenditure were just below $100 million for the year, in line with our prior comments. Looking ahead, you are all aware that as part of the process of setting order schedules for Q1 and the remainder of 2024, we learned that there is 6 million to 7 million units of excess inventory of EyeQ chips at our customers. We understand that much of this excess inventory reflects decisions by Tier 1 customers to build inventory in the basic ADAS category due to supply chain constraints and a desire to avoid part shortages in 2021 and 2022, as well as lower than expected production in certain OEMs during 2023. The inventory situation is related to the base ADAS business only, as SuperVision inventory is at normal level. As we noted in our January 4th press release and 8-K, we expect Q1 revenue to be down approximately 50% to around $230 million. We expect EyeQ volume to be around $3.4 million units in Q1. We expect SuperVision in the low 30,000 unit range, reflecting normal seasonality in China. Given the unusually low EyeQ volume, SuperVision will be a larger portion of revenues in Q1, which will result in gross margin in the mid-60 range. Extracting our operating expenses, which will likely be a bit higher than the recent $200 million run rate, the outlook for Q1 adjusted operating income is for a loss of $65 million to $80 million. But we see revenue and volume snapping back fairly quickly and believe we have very good visibility on this. Due to the nature of our business, all of this inventory is for specific OEMs and production of specific vehicle platforms. The process to clear the inventory is simply to stop shipping chips for specific vehicles and have our customer use the existing inventory to satisfy demand. There is no uncertainty regarding who the customers are, there is no alternative product that can be used, and there is no discounting or other economic action needed to clear the inventory. As we compare our prospective shipment with vehicle production schedule, we believe approximately 5 million units can be cleared in Q1 and the vast majority of the remainder in Q2. In terms of our full year guidance, it is unchanged from the preliminary outlook we provided in January 4th, and our visibility has improved over the last several weeks. From a volume perspective, we are assuming 31 million to 32 million EyeQ shipments and 175,000 to 195,000 SuperVision shipments in 2024. We expect the cadence of EyeQs assuming the midpoint of the guidance to be around [$3.4 million] (ph) in Q1, an increase of at least 100% in Q2 versus Q1, and then the balance of unit shipments in the second half of the year. We believe that this cadence, based on our analysis and discussions with customers, should result in a vast majority of excess on the inventory to be cleared by the middle of 2024. We expect average system price to increase in 2024 as compared to 2023 due to an increase of SuperVision as a percentage of total revenue. In terms of gross margin, we look at it on a product by product basis. On the ADAS side, we expect a slight down tick in growth margin this year for two reasons. One, as you know, the cost of EyeQ chips from our supplier went up at the beginning of 2023. We passed that along to our customers. However, there were a decent number of units in 2023 where we generated revenue at 2023 prices, but used [cheaper chips] (ph) in 2022 costs. That's a minor headwind this year. We are also assuming some continued normalization of production mix after a very rich mix during the supply chain crisis. We expect these two headwinds to be partially offset by higher cloud-enhanced ADAS volume and REM recurring revenue. Regarding SuperVision, the optimized domain controller is now in production. This comes at a meaningfully lower cost and we are sharing a portion of that with our customers. ASP will be down a bit compared to last year but we expect gross margin to be up meaningfully to low 40% as of Q2 2024 as compared to low to mid 30% in 2023. In addition, we would expect some level of software licensing revenue to begin making an impact in Q4 of this year once the ZEEKR free trials are over. Any consumer that chooses to pay for the SuperVision-based feature after the free trial will drive incremental revenue and profit for Mobileye. With respect to operating expenses, we are assuming 20% increase over the final 2023 number on an adjusted basis, excluding amortization of intangible asset and stock-based compensation. The OpEx bears a bit more discussion. Our forecast for 2024 is unchanged from what we projected several months ago and not too far above our original forecast for 2023. Much of the lower cost in 2023 related to more transitory things like foreign exchange and delayed moving to our new campus, good news on some engineering reimbursement and reimbursement of certain payroll costs for employees on military reserves. But some of it is structural. Certain adjustment to the way we collaborate with OEMs, including [ASP] (ph), means that SuperVision and Chauffeur programs can scale more efficiently than we originally envisioned. The refinement of our mobility-as-a-service strategy to focus on supplying the self-driving system leads to structurally lower costs, but we don't believe a reduction in the opportunity. Bottom line is that we do believe our operating expenses in the near and long term should be structurally lower than we expected as of a year ago. We continue to believe that OpEx percentage growth in 2025 and beyond should be significantly lower than in 2024. Lastly, in terms of tax rates, we are assuming a non-GAAP effective tax rate of between 15% and 17% for 2024 in comparison to 11% in 2023. Thank you and we will now take your questions.